80 related articles for article (PubMed ID: 7480367)
1. [Drug substitution treatment of heroin dependent patients with codeine preparations--treatment effects from the viewpoint of the physicians and patients].
Krausz M; Degkwitz P; Wernecke A; Verthein U; Chorzelski G; Behrendt K
Psychiatr Prax; 1995 Sep; 22(5):179-85. PubMed ID: 7480367
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients.
Wittchen HU; Apelt SM; Soyka M; Gastpar M; Backmund M; Gölz J; Kraus MR; Tretter F; Schäfer M; Siegert J; Scherbaum N; Rehm J; Bühringer G
Drug Alcohol Depend; 2008 Jun; 95(3):245-57. PubMed ID: 18337025
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
4. [Codeine and dihydrocodeine as substitute and alternative drugs].
Friessem DH; Täschner KL
Fortschr Neurol Psychiatr; 1991 May; 59(5):164-9. PubMed ID: 1869234
[TBL] [Abstract][Full Text] [Related]
5. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
6. Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study.
Bandettini Di Poggio A; Fornai F; Paparelli A; Pacini M; Perugi G; Maremmani I
Ann N Y Acad Sci; 2006 Aug; 1074():438-45. PubMed ID: 17105942
[TBL] [Abstract][Full Text] [Related]
7. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
8. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine for acute heroin detoxification: diffusion of research into practice.
Kovas AE; McFarland BH; McCarty DJ; Boverman JF; Thayer JA
J Subst Abuse Treat; 2007 Mar; 32(2):199-206. PubMed ID: 17306728
[TBL] [Abstract][Full Text] [Related]
10. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
[TBL] [Abstract][Full Text] [Related]
11. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
12. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
[TBL] [Abstract][Full Text] [Related]
14. A prospective cohort study on orally administered heroin substitution for severely addicted opioid users.
Frick U; Rehm J; Kovacic S; Ammann J; Uchtenhagen A
Addiction; 2006 Nov; 101(11):1631-9. PubMed ID: 17034443
[TBL] [Abstract][Full Text] [Related]
15. Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom.
Metrebian N; Mott J; Carnwath Z; Carnwath T; Stimson GV; Sell L
Eur Addict Res; 2007; 13(3):144-7. PubMed ID: 17570910
[TBL] [Abstract][Full Text] [Related]
16. [Heroin-assisted treatment of opiate addicts--former and current research emphasis].
Steffen T; Kaufmann B; Blättler R; Dobler-Mikola A; Gutzwiller F; Uchtenhagen A
Gesundheitswesen; 1999; 61(8-9):407-12. PubMed ID: 10535222
[TBL] [Abstract][Full Text] [Related]
17. The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
Darke S; Ross J; Teesson M
Drug Alcohol Rev; 2007 Jan; 26(1):49-54. PubMed ID: 17364836
[TBL] [Abstract][Full Text] [Related]
18. [Substitution treatment of drug-dependent patients].
Sonntag I
Gesundheitswesen; 1995 Jan; 57(1):36-8. PubMed ID: 7888722
[TBL] [Abstract][Full Text] [Related]
19. Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?
Gerra G; Maremmani I; Capovani B; Somaini L; Berterame S; Tomas-Rossello J; Saenz E; Busse A; Kleber H
Subst Use Misuse; 2009; 44(5):663-71. PubMed ID: 19360539
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
